Snapshot: Chromatin Remodeling: ISWI Adam N

Total Page:16

File Type:pdf, Size:1020Kb

Snapshot: Chromatin Remodeling: ISWI Adam N SnapShot: Chromatin Remodeling: ISWI Adam N. Yadon and Toshio Tsukiyama Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA Saccharomyces cerevisiae Caenorhabditis elegans Trypanosoma brucei Isw2 Isw2 Isw1a Isw1b NURF ISWI Itc1 Itc1 Dls1 Ioc3 Ioc4 Ioc2 NURF1 ? Dpb4 Isw1 Isw2 Isw2 Isw1 Isw1 Isw1 Replication, transcription, and Transcription regulation2 3 4 Ty1 integration regulation1 Cell fate determination Transcription regulation Drosophila melanogaster Arabidopsis thaliana ACF CHRAC NURF RSF CHR11 CHR17 ACF1 CHRAC NURF38 ? ACF1 RSF1 15 NURF301 ? CHRAC ISWI ISWI 16 ISWI RbAp ISWI CHR11 CHR17 46/48 Nucleosome assembly, transcription, Chromatin structure and Chromatin structure and Developmental cellular 5 6 7 expansion and Functions unknown and replication regulation transcription regulation transcription regulation nuclear divisions8 Mammals Xenopus laevis ACF1 CHRAC RSF CERF ACF WICH ACF1 ACF1 CHRAC ACF1 15 RSF1 CECR2 WSTF CHRAC SNF2L SNF2H SNF2H 17 SNF2H ISWI p175 ISWI Chromatin structure and Replication and transcription regulation9 Development and Heterochromatin formation centromere maintenance10 transcription regulation11 Functions unknown and/or replication regulation12 NoRC WICH WCRF NURF ISWI-A ISWI-D p15 TIP5 WSTF WCRF180 p70 p200 BPTF p200 p21 p55 SNF2L RbAp SNF2H SNF2H SNF2H ISWI ISWI 46/48 p17 13 DNA replication and Cell differentiation and Transcription regulation repair regulation14 Functions unknown transcription regulation15 Functions unknown Functions unknown Biochemical Activities Nucleosome sliding ATP ADP ISWI Histone replacement ATP ADP Histones + General domain structure ISWI Helicase SANT DEXD ATPase HAND SLIDE 454 Cell 144, February 4, 2011 ©2011 Elsevier Inc. DOI 10.1016/j.cell.2011.01.019 See online version for legend and references SnapShot: Chromatin Remodeling: ISWI Adam N. Yadon and Toshio Tsukiyama Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA The imitation switch (ISWI) family of ATP-dependent chromatin-remodeling enzymes comprises highly conserved protein complexes that utilize the energy of ATP hydrolysis to slide nucleosomes along DNA and/or replace histones within nucleosomes. All ATP-dependent chromatin-remodeling complexes, including the ISWI family, contain a conserved catalytic DEXD ATPase domain and a helicase domain. However, the combination of three C-terminally located domains, known as HAND, SANT, and SLIDE, is unique to ISWI family members. The SANT domain (structurally related to the c-Myb DNA-binding domains) binds unmodified histone tails, the SLIDE (SANT-like ISWI domain) domain binds nucleosomal DNA near the dyad axis, and the HAND domain is implicated in both histone and DNA binding/recognition. Representative ISWI-containing protein complexes from multiple species are depicted in this SnapShot, with specific in vivo biological functions for each listed below. Biological Functions of ISWI-Containing Complexes 1. Replication, Transcription, and Ty Integration Regulation Facilitates replication fork progression through late-replicating regions; represses mRNA and cryptic noncoding RNA transcription by negatively regulating NFR size; required for the periodic integration pattern of the Ty1 retrotransposon. 2. Transcription Regulation Represses and activates transcription at a small number of loci and is implicated in transcription elongation and termination regulation. 3. Cell Fate Determination Promotes the expression of vulval cell fates by antagonizing the transcriptional and chromatin-remodeling activities of complexes similar to Myb-MuvB/dREAM, NuRD, and Tip60/NuA4. 4. Transcription Regulation Downregulates VSV expression sites. 5. Nucleosome Assembly, Transcription, and Replication Regulation Required for the establishment and/or maintenance of periodic nucleosome arrays that contributes to pericentric position-effect variegation (PEV) and heterochromatic Poly- comb-mediated transcriptional gene silencing; implicated in the regulation of S phase length/progression. 6. Chromatin Structure and Transcription Regulation Maintains higher-order chromatin structure by mediating chromatin compaction; disrupts the enhancer-blocking function of Fab7 and SF1 while augmenting the function of Fab8; activates transcription of GAGA target genes and ecdysone-responsive genes and is a coactivator of Armadillo; regulates innate immunity by repressing transcription of JAK/STAT target genes. 7. Chromatin Structure and Transcription Regulation Involved in formation of silent heterochromatin by incorporating the histone variant H2Av, thus suppressing position-effect variegation (PEV). 8. Developmental Cellular Expansion and Nuclear Divisions Necessary for cell expansion during late-diploid (sporophytic) embryogenesis and mitotic nuclear divisions during haploid (gametophytic) phase. 9. Replication and Transcription Regulation Required for S phase progression and facilitates pericentromeric heterochromatin DNA replication; represses transcription of the vitamin D3 receptor-regulated genes in humans. 10. Chromatin Structure and Centromere Maintenance Implicated in chromatin assembly and actively supports the assembly of CENP-A chromatin in humans. 11. Development and Transcription Regulation Functions in neural tube formation and terminal differentiation of ovarian granulose cells through regulation of StAR gene expression in mice. 12. Heterochromatin Formation and/or Replication Regulation Targeted to pericentromeric heterochromatin during early stages of chromosome condensation and DNA replication. 13. Transcription Regulation Involved in the transcriptional repression of ribosomal RNA genes. 14. DNA Replication and Repair Regulation Implicated in heterochromatin DNA replication by binding PCNA in mice; necessary for cell survival following DNA damage by methyl methanesulfate (MMS); and facilitates a DNA damage response pathway by controlling histone H2A.Z function in mice. 15. Cell Differentiation and Transcription Regulation Promotes neurite outgrowth and transcription of engrailed 1 and 2 in humans. ACKNOWLEDGMENTS T.T. is funded by NIGMS. A.N.Y. was supported by a Developmental Biology Predoctoral Training Grant T32HD007183 from the National Institute of Child Health and Human Develop- ment. REFERENCES Bowman, G.D. (2010). Mechanisms of ATP-dependent nucleosome sliding. Curr. Opin. Struct. Biol. 20, 73–81. Clapier, C.R., and Cairns, B.R. (2009). The biology of chromatin remodeling complexes. Annu. Rev. Biochem. 78, 273–304. Dang, W., and Bartholomew, B. (2007). Domain architecture of the catalytic subunit in the ISW2-nucleosome complex. Mol. Cell. Biol. 27, 8306–8317. Gangaraju, V.K., Prasad, P., Srour, A., Kagalwala, M.N., and Bartholomew, B. (2009). Conformational changes associated with template commitment in ATP-dependent chromatin remodeling by ISW2. Mol. Cell 35, 58–69. Whitehouse, I., Rando, O.J., Delrow, J., and Tsukiyama, T. (2007). Chromatin remodelling at promoters suppresses antisense transcription. Nature 450, 1031–1035. Yadon, A.N., Van de Mark, D., Basom, R., Delrow, J., Whitehouse, I., and Tsukiyama, T. (2010). Chromatin remodeling around nucleosome-free regions leads to repression of noncod- ing RNA transcription. Mol. Cell. Biol. 30, 5110–5122. 454.e1 Cell 144, February 4, 2011 ©2011 Elsevier Inc. DOI 10.1016/j.cell.2011.01.019 .
Recommended publications
  • RSF1 Regulates the Proliferation and Paclitaxel Resistance Via Modulating
    Journal of Cancer 2017, Vol. 8 354 Ivyspring International Publisher Journal of Cancer 2017; 8(3): 354-362. doi: 10.7150/jca.16720 Research Paper RSF1 regulates the proliferation and paclitaxel resistance via modulating NF-κB signaling pathway in nasopharyngeal carcinoma Yong Liu1,2, Guo Li1,2, Chao Liu1,2, Yaoyun Tang1,2, Shuai Zhang1,2 1. Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha 410008, Hunan, China. 2. Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha, 410008, Hunan, China. Corresponding author: Shuai Zhang, Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Changsha 410008, Hunan, China. Tel.: +86073184327469; Fax: +86073184327469; E-mail: [email protected] (Zhang Shuai). © Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2016.07.04; Accepted: 2016.10.15; Published: 2017.02.09 Abstract Purpose: Aberrant expression and dysfunction of RSF1 has been reported in diverse human malignancies. However, its exact role in nasopharyngeal carcinoma (NPC) remains unclear. Methods: The expression of RSF1 mRNA and protein were assayed by qRT-PCR and western blotting, and their correlations with clinicopathological parameters of patients with NPC were further analysed. Lentivirus mediated RSF1 shRNA and RSF1 cDNA were used to knockdown and upregulate the expression of RSF1. CCK8 assays and flow cytometry were applied to monitor the changes of proliferation and paclitaxel sensitivity caused by RSF1 modulation, inhibition of NF-κB pathway by inhibitor Bay 11-7082 and Survivin knockdown.
    [Show full text]
  • Wo 2010/075007 A2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 1 July 2010 (01.07.2010) WO 2010/075007 A2 (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C12Q 1/68 (2006.01) G06F 19/00 (2006.01) kind of national protection available): AE, AG, AL, AM, C12N 15/12 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US2009/067757 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 11 December 2009 ( 11.12.2009) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, (26) Publication Language: English TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 12/3 16,877 16 December 2008 (16.12.2008) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, (71) Applicant (for all designated States except US): DODDS, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, W., Jean [US/US]; 938 Stanford Street, Santa Monica, TM), European (AT, BE, BG, CH, CY, CZ, DE, DK, EE, CA 90403 (US).
    [Show full text]
  • Glia Are Essential for Sensory Organ Function in C. Elegans
    REPORTS commercial and recreational fisheries are com- tion will be disproportionately affected by higher 10. A. N. LeGrande, G. A. Schmidt, Geophys. Res. Lett. 33, posed of both populations of bluefin tuna (Fig. fishing rates in the eastern management zone. L12604 (2006). 11. J. Ashford, C. Jones, Geochim. Cosmochim. Acta 71,87 2). A large fraction of the school (57.4%) and The disparity between the eastern and western (2007). medium (44.3%) category bluefin tuna present in population sizes and the continued decline of the 12. R. B. Millar, Can. J. Fish. Aquat. Sci. 44, 583 (1987). the U.S. waters of the Mid Atlantic Bight were western stock suggests that some added level of 13. G. H. Rau, T. Takahashi, D. J. Des Marais, Nature 341, from the eastern population, and we observed protection is needed to ensure the sustainability 516 (1989). 14. S. L. H. Teo et al., Mar. Biol. (Berlin) 151, 1 (2007). that the occurrence of eastern bluefin tuna in the of the smaller western component. Natal homing 15. J. Carlsson, J. R. McDowell, J. E. L. Carlsson, J. E. Graves, Mid Atlantic Bight decreased with increasing rates reported here were remarkably high to both J. Hered. 98, 23 (2007). size (age) (Fig. 3). Our estimates of trans-Atlantic regions and clearly show that the contribution of 16. T. P. Quinn, Fish. Res. 18, 29 (1993). exchange were significantly higher than previous eastern adults to the western spawning area is 17. J. R. Baker, G. A. Antonelis, C. W. Fowler, A. E. York, reports from conventional tags (3) and demon- inconsequential.
    [Show full text]
  • Supp Table 6.Pdf
    Supplementary Table 6. Processes associated to the 2037 SCL candidate target genes ID Symbol Entrez Gene Name Process NM_178114 AMIGO2 adhesion molecule with Ig-like domain 2 adhesion NM_033474 ARVCF armadillo repeat gene deletes in velocardiofacial syndrome adhesion NM_027060 BTBD9 BTB (POZ) domain containing 9 adhesion NM_001039149 CD226 CD226 molecule adhesion NM_010581 CD47 CD47 molecule adhesion NM_023370 CDH23 cadherin-like 23 adhesion NM_207298 CERCAM cerebral endothelial cell adhesion molecule adhesion NM_021719 CLDN15 claudin 15 adhesion NM_009902 CLDN3 claudin 3 adhesion NM_008779 CNTN3 contactin 3 (plasmacytoma associated) adhesion NM_015734 COL5A1 collagen, type V, alpha 1 adhesion NM_007803 CTTN cortactin adhesion NM_009142 CX3CL1 chemokine (C-X3-C motif) ligand 1 adhesion NM_031174 DSCAM Down syndrome cell adhesion molecule adhesion NM_145158 EMILIN2 elastin microfibril interfacer 2 adhesion NM_001081286 FAT1 FAT tumor suppressor homolog 1 (Drosophila) adhesion NM_001080814 FAT3 FAT tumor suppressor homolog 3 (Drosophila) adhesion NM_153795 FERMT3 fermitin family homolog 3 (Drosophila) adhesion NM_010494 ICAM2 intercellular adhesion molecule 2 adhesion NM_023892 ICAM4 (includes EG:3386) intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)adhesion NM_001001979 MEGF10 multiple EGF-like-domains 10 adhesion NM_172522 MEGF11 multiple EGF-like-domains 11 adhesion NM_010739 MUC13 mucin 13, cell surface associated adhesion NM_013610 NINJ1 ninjurin 1 adhesion NM_016718 NINJ2 ninjurin 2 adhesion NM_172932 NLGN3 neuroligin
    [Show full text]
  • LN-EPC Vs CEPC List
    Supplementary Information Table 5. List of genes upregulated on LN-EPC (LCB represents the variation of gene expression comparing LN-EPC with CEPC) Gene dystrophin (muscular dystrophy, Duchenne and Becker types) regulator of G-protein signalling 13 chemokine (C-C motif) ligand 8 vascular cell adhesion molecule 1 matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) chemokine (C-C motif) ligand 2 solute carrier family 2 (facilitated glucose/fructose transporter), member 5 eukaryotic translation initiation factor 1A, Y-linked regulator of G-protein signalling 1 ubiquitin D chemokine (C-X-C motif) ligand 3 transcription factor 4 chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 transcription factor 4 apolipoprotein D RAS guanyl releasing protein 3 (calcium and DAG-regulated) matrix metalloproteinase 1 (interstitial collagenase) DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked /// DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked transcription factor 4 regulator of G-protein signalling 1 B-cell linker interleukin 8 POU domain, class 2, associating factor 1 CD24 antigen (small cell lung carcinoma cluster 4 antigen) Consensus includes gb:AK000168.1 /DEF=Homo sapiens cDNA FLJ20161 fis, clone COL09252, highly similar to L33930 Homo sapiens CD24 signal transducer mRNA. /FEA=mRNA /DB_XREF=gi:7020079 /UG=Hs.332045 Homo sapiens cDNA FLJ20161 fis, clone COL09252, highly similar to L33930 Homo sapiens CD24 signal transducer mRNA
    [Show full text]
  • Drosophila and Human Transcriptomic Data Mining Provides Evidence for Therapeutic
    Drosophila and human transcriptomic data mining provides evidence for therapeutic mechanism of pentylenetetrazole in Down syndrome Author Abhay Sharma Institute of Genomics and Integrative Biology Council of Scientific and Industrial Research Delhi University Campus, Mall Road Delhi 110007, India Tel: +91-11-27666156, Fax: +91-11-27662407 Email: [email protected] Nature Precedings : hdl:10101/npre.2010.4330.1 Posted 5 Apr 2010 Running head: Pentylenetetrazole mechanism in Down syndrome 1 Abstract Pentylenetetrazole (PTZ) has recently been found to ameliorate cognitive impairment in rodent models of Down syndrome (DS). The mechanism underlying PTZ’s therapeutic effect is however not clear. Microarray profiling has previously reported differential expression of genes in DS. No mammalian transcriptomic data on PTZ treatment however exists. Nevertheless, a Drosophila model inspired by rodent models of PTZ induced kindling plasticity has recently been described. Microarray profiling has shown PTZ’s downregulatory effect on gene expression in fly heads. In a comparative transcriptomics approach, I have analyzed the available microarray data in order to identify potential mechanism of PTZ action in DS. I find that transcriptomic correlates of chronic PTZ in Drosophila and DS counteract each other. A significant enrichment is observed between PTZ downregulated and DS upregulated genes, and a significant depletion between PTZ downregulated and DS dowwnregulated genes. Further, the common genes in PTZ Nature Precedings : hdl:10101/npre.2010.4330.1 Posted 5 Apr 2010 downregulated and DS upregulated sets show enrichment for MAP kinase pathway. My analysis suggests that downregulation of MAP kinase pathway may mediate therapeutic effect of PTZ in DS. Existing evidence implicating MAP kinase pathway in DS supports this observation.
    [Show full text]
  • Mouse Rsf1 Conditional Knockout Project (CRISPR/Cas9)
    https://www.alphaknockout.com Mouse Rsf1 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Rsf1 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Rsf1 gene (NCBI Reference Sequence: NM_001081267 ; Ensembl: ENSMUSG00000035623 ) is located on Mouse chromosome 7. 16 exons are identified, with the ATG start codon in exon 1 and the TAA stop codon in exon 16 (Transcript: ENSMUST00000107153). Exon 4 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Rsf1 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP24-66B7 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a conditional allele activated in neurons exhibit increased susceptibility to etoposide-induced neuron apoptosis with failure to repair double-strand breaks. Exon 4 starts from about 8.98% of the coding region. The knockout of Exon 4 will result in frameshift of the gene. The size of intron 3 for 5'-loxP site insertion: 2835 bp, and the size of intron 4 for 3'-loxP site insertion: 13542 bp. The size of effective cKO region: ~706 bp. The cKO region does not have any other known gene. Page 1 of 9 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 4 16 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Rsf1 Homology arm cKO region loxP site Page 2 of 9 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats.
    [Show full text]
  • Identification of Molecular Vulnerabilities in Human Multiple Myeloma Cells by RNA Interference Lethality Screening of the Druggable Genome
    Published OnlineFirst December 6, 2011; DOI: 10.1158/0008-5472.CAN-11-2781 Cancer Therapeutics, Targets, and Chemical Biology Research Identification of Molecular Vulnerabilities in Human Multiple Myeloma Cells by RNA Interference Lethality Screening of the Druggable Genome Rodger E. Tiedemann1, Yuan Xao Zhu2, Jessica Schmidt2, Chang Xin Shi2, Chris Sereduk3, Hongwei Yin3, Spyro Mousses3, and A. Keith Stewart2 Abstract Despite recent advances in targeted treatments for multiple myeloma, optimal molecular therapeutic targets have yet to be identified. To functionally identify critical molecular targets, we conducted a genome-scale lethality study in multiple myeloma cells using siRNAs. We validated the top 160 lethal hits with four siRNAs per gene in three multiple myeloma cell lines and two non-myeloma cell lines, cataloging a total of 57 potent multiple myeloma survival genes. We identified the Bcl2 family member MCL1 and several 26S proteasome subunits among the most important and selective multiple myeloma survival genes. These results provided biologic validation of our screening strategy. Other essential targets included genes involved in RNA splicing, ubiquitina- tion, transcription, translation, and mitosis. Several of the multiple myeloma survival genes, especially MCL1, TNK2, CDK11, and WBSCR22, exhibited differential expression in primary plasma cells compared with other human primary somatic tissues. Overall, the most striking differential functional vulnerabilities between multiple myeloma and non–multiple myeloma cells were
    [Show full text]
  • Chromatin-Remodeling Factor, RSF1, Controls P53-Mediated Transcription
    Min et al. Cell Death and Disease (2018) 9:1079 DOI 10.1038/s41419-018-1128-2 Cell Death & Disease ARTICLE Open Access Chromatin-remodeling factor, RSF1, controls p53-mediated transcription in apoptosis upon DNA strand breaks Sunwoo Min1,2, Keeeun Kim1,3, Seong-Gwang Kim1,2,3, Hyeseong Cho 1,2,3,4 and Youngsoo Lee 1,3,4 Abstract Remodeling and spacing factor 1 (RSF1), which is one of chromatin-remodeling factors, has been linked to the DNA damage response (DDR) and DNA repair. However, the biological consequence of RSF1 deficiency in DDR in vivo and its molecular mechanisms remain unknown. Because defective DDR is related to neuropathological phenotypes, we developed neural-specific Rsf1 knockout mice. Rsf1 deficiency did not result in any neuropathological abnormalities, but prevented neural apoptosis triggered by excessive DNA strand breaks during neurogenesis. Likewise, cell death was significantly reduced in RSF1 deficient human cell lines after DNA damage, and the global transcriptome of these cells revealed that the expressions of p53 downstream genes were significantly reduced upon DNA strand breaks. Inactivation of these genes resulted from decreased binding of p53/p300 complex and subsequent reduction of H3 acetylation at their promoters. Our data show that RSF1 is necessary for p53-dependent gene expression in response to DNA strand breaks via controlling the accessibility of p53/p300 complex to its target genes and contributes to the maintenance of cellular integrity. 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; Introduction Remodeling and spacing factor 1 (RSF1) is a chromatin- Genomic stability is fundamental for proper develop- remodeling factor initially identified as a transcriptional ment and lifelong functioning, and DNA repair pathways activator with the FACT (facilitates chromatin transcrip- are crucial to counteract the various endogenous and tion) complex.
    [Show full text]
  • Antagonism Between RSF1 and SR Proteins for Both Splice-Site Recognition in Vitro and Drosophila Development
    Downloaded from genesdev.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Antagonism between RSF1 and SR proteins for both splice-site recognition in vitro and Drosophila development Emmanuel Labourier,1,5 Henri-Marc Bourbon,2,5 Imed-eddine Gallouzi,1,3 Maggy Fostier,2,4 Eric Allemand,1 and Jamal Tazi1,6 1Institut de Ge´ne´tique Mole´culaire, Centre National de la Recherche Scientifique (CNRS), F34293 Montpellier Cedex 5, France; 2Centre de Biologie du De´veloppement, CNRS, Universite´Paul Sabatier, F31062 Toulouse, France Specific recognition of splice sites within metazoan mRNA precursors (pre-mRNAs) is a potential stage for gene regulation by alternative splicing. Splicing factors of the SR protein family play a major role in this regulation, as they are required for early recognition of splice sites during spliceosome assembly. Here, we describe the characterization of RSF1, a splicing repressor isolated from Drosophila, that functionally antagonizes SR proteins. Like the latter, RSF1 comprises an amino-terminal RRM-type RNA-binding domain, whereas its carboxy-terminal part is enriched in glycine (G), arginine (R), and serine (S) residues (GRS domain). RSF1 induces a dose-sensitive inhibition of splicing for several reporter pre-mRNAs, an inhibition that occurs at the level of early splicing complexes formation. RSF1 interacts, through its GRS domain, with the RS domain of the SR protein SF2/ASF and prevents the latter from cooperating with the U1 small nuclear ribonucleoprotein particle (U1 snRNP) in binding pre-mRNA. Furthermore, overproduction of RSF 1 in the fly rescues several developmental defects caused by overexpression of the splicing activator SR protein B52/ SRp55.
    [Show full text]
  • The Role of Genetic Polymorphisms in Endolysosomal Ion
    www.nature.com/npjgenmed ARTICLE OPEN The role of genetic polymorphisms in endolysosomal ion channels TPC2 and P2RX4 in cancer pathogenesis, prognosis, and diagnosis: a genetic association in the UK Biobank ✉ Abeer F. Alharbi1,2 and John Parrington 1 Recent studies have implicated important roles for endolysosomal ion channels in cancer biology. We used UK Biobank data to characterise the relationships between genetic variants in two genes coding for endolysosomal ion channels—i.e. TPCN2 and P2RX4 —and cancer in terms of the definition of tumour types, susceptibility, and prognosis. We investigated these relationships at both global and local levels with regard to specific types of cancer, including malignant neoplasms of the brain, breast, bronchus, lung, colon, lymphoid and haematopoietic systems, skin, ovary, prostate, rectum, thyroid gland, lip, oral cavity, pharynx, and urinary tract. Apart from rs3829241 (p value < 0.05), all the genetic variants were in Hardy–Weinberg equilibrium. We included 468,436 subjects in the analysis and stratified them into two major cohorts: cancer-free controls (385,253) and cancer cases (83,183). For the first time, we report novel associations between genetic variants of TPCN2 and P2RX4 and cancer/cancer subtypes in the UK Biobank’s population. Genotype GG in TPCN2 rs3750965 was significantly associated with a decreased risk of cancer and an increased risk of lip, oral cavity, and pharynx cancer and cancer recurrence in patients with prostate cancer, and genotypes GA/GG were associated with a significantly lower risk of developing various malignant neoplasms (involving melanoma, prostate, mesothelial, and soft 1234567890():,; tissues). rs35264875:TA was associated with a high risk of cancer at the global level, with subtypes of cancer at the local level (including breast, colon, prostate, and stated or presumed primary cancer of lymphoid, haematopoietic, and related tissue), and with a significantly low risk of cancer metastasis.
    [Show full text]
  • The Chromatin Remodeller RSF1 Is Essential for PLK1 Deposition and Function at Mitotic Kinetochores
    ARTICLE Received 10 Dec 2014 | Accepted 22 Jun 2015 | Published 10 Aug 2015 DOI: 10.1038/ncomms8904 OPEN The chromatin remodeller RSF1 is essential for PLK1 deposition and function at mitotic kinetochores Ho-Soo Lee1,2, Yong-Yea Park1, Mi-Young Cho1,2, Sunyoung Chae1, Young-Suk Yoo1,2, Myung-Hee Kwon2,3, Chang-Woo Lee4 & Hyeseong Cho1,2 Accumulation of PLK1 at kinetochores is essential for chromosome alignment and segregation; however, the mechanism underlying PLK1 recruitment to kinetochores remains unresolved. The chromatin remodeller RSF1 tightly associates with centromere proteins, but its mitotic function is unknown. Here we show that RSF1 localizes at mitotic kinetochores and directly binds PLK1. RSF1 depletion disrupts localization of PLK1 at kinetochores; the C-terminal fragment of RSF1, which can bind PLK1, is sufficient to restore PLK1 localization. Moreover, CDK1 phosphorylates RSF1 at Ser1375, and this phosphorylation is necessary for PLK1 recruitment. Subsequently, PLK1 phosphorylates RSF1 at Ser1359, stabilizing PLK1 deposition. Importantly, RSF1 depletion mimicks the chromosome misalignment phenotype resulting from PLK1 knockdown; these defects are rescued by RSF1 S1375D or RSF1 S1359D but not RSF1 S1375A, showing a functional link between phosphorylation of RSF1 and chromosome alignment. Together, these data show that RSF1 is an essential centromeric component that recruits PLK1 to kinetochores and plays a crucial role in faithful cell division. 1 Department of Biochemistry, Ajou University School of Medicine, Suwon 443-380, Korea. 2 Department of Biomedical Sciences, Graduate School of Ajou University, Suwon 443-380, Korea. 3 Department of Microbiology, Ajou University School of Medicine, Suwon 443-380, Korea. 4 Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon 440-746, Korea.
    [Show full text]